Single vs. double intracoronary injection of mesenchymal stromal cell after acute myocardial infarction: the study protocol from a randomized clinical trial: BOOSTER-TAHA7 trial.
Armin AttarFatemeh NouriArash YazdanshenasKamran HessamiMassoud VosoughAlireza Abdi-ArdekaniPeyman IzadpanahMani RamziJavad KojouriGholamreza PouladfarAhmad MonabatiPublished in: Trials (2022)
Iranian Registry of Clinical Trials ( www.IRCT.ir ) IRCT20201116049408N1. Registered on November 26 2020.
Keyphrases
- clinical trial
- study protocol
- acute myocardial infarction
- bone marrow
- phase ii
- phase iii
- randomized controlled trial
- open label
- single cell
- stem cells
- percutaneous coronary intervention
- cell therapy
- double blind
- left ventricular
- st elevation myocardial infarction
- ultrasound guided
- coronary artery disease
- mesenchymal stem cells
- heart failure